Divi's Laboratories
Search results
Press Release - Laurus Labs Financial Results Q3 FY 2024 We value your privacy We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic.By Clicking “Accept”, you consent to our use of cookies.
About Us. As a research-driven pharmaceutical manufacturing organization, Laurus Labs has been developing and assisting its client organizations to succeed in innovative medicines that globally enhance the health outcomes for patients. Since our inception in 2005, we have been developing and manufacturing Active Pharmaceutical Ingredients (APIs ...
Laurus Labs shares erase intraday losses to swing into green, Motilal Oswal sees 13% upside Apr 26 2024 01:39 PM. Laurus Labs: CDMO services key to improved prospects, say analysts Apr 26 2024 01: ...
Laurus Labs. Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, [7] veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom ...
Press Release - Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction May 02, 2023 Press Release - Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film (ODF) drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment
4 days ago · Laurus Labs Limited Share Price Today, Live NSE Stock Price: Get the latest Laurus Labs Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results and more details at NSE India.
